191 related articles for article (PubMed ID: 19949927)
1. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
Chang XB
Methods Mol Biol; 2010; 596():223-49. PubMed ID: 19949927
[TBL] [Abstract][Full Text] [Related]
2. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.
Chang XB
Cancer Metastasis Rev; 2007 Mar; 26(1):15-37. PubMed ID: 17295059
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport.
Yang R; Chang XB
Biochim Biophys Acta; 2007 Feb; 1768(2):324-35. PubMed ID: 17187755
[TBL] [Abstract][Full Text] [Related]
5. MRP1 and its role in anticancer drug resistance.
Lu JF; Pokharel D; Bebawy M
Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
[TBL] [Abstract][Full Text] [Related]
6. Probing ATP-dependent conformational changes in the multidrug resistance protein 1 (MRP1/ABCC1) in live tumor cells with a novel recombinant single-chain Fv antibody targeted to the extracellular N-terminus.
Binyamin L; Assaraf YG; Reiter Y
Int J Cancer; 2005 Sep; 116(5):703-9. PubMed ID: 15838832
[TBL] [Abstract][Full Text] [Related]
7. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily.
Altenberg GA
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):53-62. PubMed ID: 14754412
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance in cancer: role of ATP-dependent transporters.
Gottesman MM; Fojo T; Bates SE
Nat Rev Cancer; 2002 Jan; 2(1):48-58. PubMed ID: 11902585
[TBL] [Abstract][Full Text] [Related]
9. The role of multidrug transporters in drug availability, metabolism and toxicity.
Bodó A; Bakos E; Szeri F; Váradi A; Sarkadi B
Toxicol Lett; 2003 Apr; 140-141():133-43. PubMed ID: 12676459
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets.
Nagengast WB; Oude Munnink TH; Dijkers EC; Hospers GA; Brouwers AH; Schröder CP; Lub-de Hooge M; de Vries EG
Methods Mol Biol; 2010; 596():15-31. PubMed ID: 19949918
[TBL] [Abstract][Full Text] [Related]
11. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
Buyse F; Hou YX; Vigano C; Zhao Q; Ruysschaert JM; Chang XB
Biochem J; 2006 Jul; 397(1):121-30. PubMed ID: 16551273
[TBL] [Abstract][Full Text] [Related]
12. [Multidrug resistance-associated proteins and their roles in multidrug resistance].
Zhang H; Fu LW
Yao Xue Xue Bao; 2011 May; 46(5):479-86. PubMed ID: 21800532
[TBL] [Abstract][Full Text] [Related]
13. Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer.
Dhasmana D; Singh A; Shukla R; Tripathi T; Garg N
Sci Rep; 2018 Aug; 8(1):11973. PubMed ID: 30097643
[TBL] [Abstract][Full Text] [Related]
14. Importance of ABCC1 for cancer therapy and prognosis.
Kunická T; Souček P
Drug Metab Rev; 2014 Aug; 46(3):325-42. PubMed ID: 24670052
[TBL] [Abstract][Full Text] [Related]
15. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
Coley HM
Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms for tumour resistance to chemotherapy.
Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
[TBL] [Abstract][Full Text] [Related]
17. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
Munoz M; Henderson M; Haber M; Norris M
IUBMB Life; 2007 Dec; 59(12):752-7. PubMed ID: 18085475
[TBL] [Abstract][Full Text] [Related]
18. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.
Jaiswal R; Raymond Grau GE; Bebawy M
Future Oncol; 2014 Mar; 10(4):655-69. PubMed ID: 24754595
[TBL] [Abstract][Full Text] [Related]
19. [Transmembrane transporters ABCC - structure, function and role in multidrug resistance of cancer cells].
Dębska S; Owecka A; Czernek U; Szydłowska-Pazera K; Habib M; Potemski P
Postepy Hig Med Dosw (Online); 2011 Aug; 65():552-61. PubMed ID: 21918258
[TBL] [Abstract][Full Text] [Related]
20. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O
Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
